Translating discovery & preclinical results into predictive clinical validation in the field of metabolic and cardiovascular disorders
Physiogenex is a world leading CRO specializing in preclinical discovery services for biopharmaceutical and nutraceutical companies.
Physiogenex has rapidly achieved global player status by virtue of its unique expertise covering complex metabolic disorders associated with diabetes, obesity, liver diseases, lipid disorders, hypertension and cardiovascular diseases.
Physiogenex pioneers the development of kinetic methods using radioactive labeled tracers and predictive animal nutritional models. We provide our partners with relevant and reliable in vivo preclinical data for successful strategic decision-making.
